ICD Code M65.4
ICD code M65.4 is used to identify radial styloid tenosynovitis, also known as de Quervain’s disease, for accurate diagnosis and recordkeeping.
Boost patient experience and your bottom line by automating patient cost estimates, payer underpayment detection, and contract optimization in one place.
What is ICD diagnosis code M65.4
ICD code M65.4 is radial styloid tenosynovitis, also known as de Quervain's tenosynovitis, which refers to inflammation of the tendons on the thumb side of the wrist.
When to use ICD code M65.4
1. Pain and tenderness localized over the radial (thumb) side of the wrist, especially near the base of the thumb
2. Swelling in the area of the radial styloid process
3. Positive Finkelstein’s test (pain elicited when the thumb is grasped in the palm and the wrist is ulnarly deviated)
4. Difficulty or pain with thumb movement, particularly with grasping or pinching
5. Crepitus or a catching sensation with thumb or wrist movement
6. Absence of systemic symptoms such as fever or generalized joint pain
7. No evidence of fracture, arthritis, or other underlying wrist pathology on imaging
Billable CPT codes for ICD code M65.4
Relevant CPT codes for ICD code M65.4 include:
- 20550 (Injection(s); single tendon sheath, or ligament, aponeurosis)
- 26055 (Tendon sheath incision, e.g., for trigger finger)
- 25115 (Excision of tendon sheath, wrist, flexor or extensor, single compartment)
- 25118 (Excision of tendon sheath, wrist, flexor or extensor, each additional compartment)
- 99201–99215 (Evaluation and management services, depending on visit complexity)
Are you being underpaid for encounters with M65.4
Schedule a demo to see how MD Clarity’s RevFind software can automatically read your contracts and identify underpayments for CPT codes associated with ICD code M65.4. Discover how easy it is to ensure accurate reimbursement and maximize your revenue with RevFind.
Get paid in full by bringing clarity to your revenue cycle
Related ICD Codes
Subscribe to the

Healthcare Clarified newsletter
Get the latest insights on RCM and healthcare policy in your inbox
